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Abstract. 
 
Intercellular adhesion molecule-5 (ICAM-5) 
is a dendritically polarized membrane glycoprotein in 
telencephalic neurons, which shows heterophilic bind-
 
ing to leukocyte 
 
b
 
2
 
-integrins. Here, we show that the 
human ICAM-5 protein interacts in a homophilic man-
ner through the binding of the immunoglobulin domain 
1 to domains 4–5. Surface coated ICAM-5-Fc promoted 
dendritic outgrowth and arborization of ICAM-
5–expressing hippocampal neurons. During dendrito-
genesis in developing rat brain, ICAM-5 was in mono-
mer form, whereas in mature neurons it migrated as a 
high molecular weight complex. The ﬁndings indicate 
that its homophilic binding activity was regulated by 
nonmonomer/monomer transition. Thus, ICAM-5 dis-
plays two types of adhesion activity, homophilic binding 
between neurons and heterophilic binding between 
neurons and leukocytes.
Key words: leukocyte • integrin • adhesion • dendrite 
• neuron
 
Introduction
 
Neuron–neuron contact mediated by adhesion molecules
is an important way to influence brain architecture (Hynes
and Lander, 1992; Goodman and Shatz, 1993; Walsh and
Doherty, 1997). Since neurons are polarized, extending an
axon and dendrites from the soma (Craig and Banker,
1994), neural cell adhesion molecules can be divided into
axon-associated cell adhesion molecules (AxCAMs)
 
1
 
 and
dendrite-associated cell adhesion molecules (DenCAMs;
Yoshihara et al., 1994; Brümmendorf and Rathjen, 1996).
Whereas a great deal is known about the roles of AxCAMs
in axonal elongation, fasciculation, and guidance by mech-
anisms involving transmembrane signaling pathways (Son-
deregger and Rathjen, 1992; Walsh and Doherty, 1997),
little is known about DenCAMs. However, DenCAMs are
supposed to guide the formation of dendritic fasciculation
and arborization, and to function as counter-receptors for
AxCAMs in synaptogenesis.
Intercellular adhesion molecule-5 (ICAM-5; telenceph-
alin; Yoshihara et al., 1994; Mizuno et al., 1997) is a cell
surface glycoprotein that belongs to the immunoglobulin
superfamily and shares 38–55% amino acid identity with
the other ICAMs, which play important roles as adhesion
molecules in the hematopoietic system (Springer, 1994;
Gahmberg, 1997; Hayflick et al., 1998). Many cell surface
proteins involved in cell adhesion belong to the immuno-
 
globulin superfamily. Such proteins contain a variable num-
ber of immunoglobulin domains, which are 
 
z
 
100 amino
acids long and form two 
 
b
 
-sheets. Human ICAM-5 con-
sists of nine extracellular immunoglobulin domains with a
total of 832 amino acids, a 28-amino acid transmembrane
segment, and a 64-amino acid cytoplasmic domain. Like
other ICAMs, it binds to the leukocyte integrin CD11a/
CD18 (Mizuno et al., 1997; Tian et al., 1997) and it may be
an important regulator of the immune response in the cen-
tral nervous system.
ICAM-5 has several features that make it a candidate
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Abbreviations used in this paper: 
 
AxCAM, axon-associated cell adhe-
sion molecule; D, immunoglobulin domain; DenCAM, dendrite-associ-
ated cell adhesion molecule; E19, embryonic day 19; ICAM, intercellular
 
adhesion molecule; MAP-2, microtubule-associated protein-2; P, postnatal
day; WT, wild-type. 
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for a DenCAM. Firstly, it is localized to cell somata and
dendrites of neurons, and neurons expressing ICAM-5 have
more extensive dendritic branches than neurons without
ICAM-5 (Benson et al., 1998). Secondly, it is expressed
only in the telencephalon, the most rostral segment of the
brain, and not in the caudal segments (Yoshihara and
Mori, 1994). Thirdly, the onset of its expression temporally
parallels the onset of dendritic elongation and synaptogen-
esis during the postnatal period. These facts together sup-
port the hypothesis that ICAM-5 may provide a brain seg-
ment-specific cue for synaptogenesis or dendrite–dendrite
interactions in the telencephalon. Indeed, earlier studies
have shown that ICAM-5 promotes embryonic hippocam-
pal neurite outgrowth (Tamada et al., 1998) and is in-
volved in hippocampal long-term potentiation (Sakurai et
al., 1998). However, the molecular basis has remained
poorly understood.
Here, we attempted to address this issue by studying
purified recombinant human ICAM-5 proteins, ICAM-5
transfected into a human neural crest derived cell line
(Paju), and ICAM-5 in developing rat brain. We found
that ICAM-5 induced neurite outgrowth of Paju cells and
rat hippocampal neurons through homophilic interaction,
and it also promoted the dendritic arborization of hippo-
campal neurons through homophilic binding. The adhe-
sive domains in ICAM-5 were mapped, and we propose
that the homophilic activity of ICAM-5 is regulated by a
monomer/nonmonomer transition.
 
Materials and Methods
 
Cell Culture and Immunocytostaining 
 
Wild-type Paju cells (Paju-WT) are a human neural crest-derived cell line,
which was cultured in RPMI 1640 and 10% FCS (BioWhittaker) on glass
coverslips. Paju-ICAM-5 was obtained by transfection of Paju-WT with
the human ICAM-5 in the vector pEF-BOS (Tian et al., 1997; Tamada et
al., 1998) and was cultured as above, but in the presence of 0.5 mg/ml
G418 (Sigma-Aldrich). For mAb blocking assay, Paju-ICAM-5 cells were
cultured in the presence of 100 
 
m
 
g/ml mAbs to ICAM-5 for 3 d. The anti-
bodies were made by immunizing mice with purified ICAM-5-Fc and anti-
body-producing clones identified by flow cytometry analysis. Control cells
were stained with 10 
 
m
 
g/ml mAb TL-3 after culture.
After methanol fixation, the cells were stained with FITC-conjugated
rabbit anti–mouse antiserum (Jackson ImmunoResearch Laboratories).
Cells were observed by immunofluorescence microscopy (Olympus Provis
70) at 400
 
3
 
.
 
Production of Recombinant Proteins 
 
Truncated ICAM-5 extracellular domains were cloned by PCR from hu-
man ICAM-5 cDNA, sequenced, and inserted into the pEF-Fc (Tian et
al., 1997; Tamada et al., 1998) expression vector. The recombinant pro-
teins were purified from transiently transfected COS-1 (American Type
Culture Collection) cells using protein A–Sepharose CL 4B (Amersham
Pharmacia Biotech) and their purities checked by Western blotting using
HRP-conjugated anti-human Ig (Amersham Pharmacia Biotech). Soluble
ICAM-5 immunoglobulin domain 1–9 (D1–9) without Fc was purified
from a baculovirus-expression system (Bac-to-bac system; GIBCO BRL).
 
Flow Cytometry and ELISA 
 
10
 
6
 
 Paju-WT and Paju-ICAM-5 cells were first incubated with 100 
 
m
 
g/ml
recombinant ICAM-5-Fc, ICAM-1-Fc, and NCAM-Fc proteins, followed
by FITC-conjugated anti-human IgG (Dako) at room temperature for
30 min. After washings, samples were analyzed with FACScan and
CellQuest software (Becton Dickinson). The mean fluorescent value of
 
Paju-ICAM-5 was subtracted with that of Paju-WT for each recombinant
protein. For ELISA, 5 
 
m
 
g/ml recombinant proteins were coated on micro-
titer plates, blocked with BSA (Sigma-Aldrich), and then incubated first
with biotinylated domains 1–2 Fc (D1–2-Fc; Pierce) of ICAM-5, and then
with HRP-conjugated streptavidin (Pierce Chemical Co.) at 37
 
8
 
C for 1 h,
and the color measured at 492 nm. For mAb blocking assay, 5 
 
m
 
g/ml
ICAM-5 D1–9 was coated and preincubated with anti–ICAM-5 mAbs at
room temperature for 30 min, followed by the steps mentioned above.
 
Native PAGE and Western Blotting 
 
Brains of embryonic (embryonic day 19, E19), newborn (postnatal day
1–10, P1-10), and adult rats were homogenized in 10 mM Tris, 1 mM
EDTA, 10 mM Chaps, 300 mM NaCl, and 1 mM PMSF. Paju-ICAM-5
cells were treated with 5 
 
m
 
M cytochalasin D (Calbiochem-Novabiochem)
or 0.5 mg/ml ICAM-5 D1–2-Fc protein for 8 or 4 h, respectively, and were
then lysed with the same buffer. Brain homogenates or cell lysates were
run on native PAGE with PhastGel 4-15 (Amersham Pharmacia Biotech)
and blotted onto nitrocellulose membranes. ICAM-5 protein was detected
by a polyclonal antibody against the cytoplasmic part of mouse ICAM-5
(Tian et al., 1997).
 
Neurite Outgrowth Assay 
 
0.5 
 
m
 
g of D1–2-Fc or D1–9-Fc of ICAM-5 and ICAM-1-Fc proteins were
coated in drops on coverslips in 24-well plates. After blocking, the cover-
slips with BSA, 10
 
4
 
/well Paju-WT and Paju-ICAM-5 cells were seeded and
cultured for 30–36 h. For mAb inhibition assay, 50 
 
m
 
g/ml mAb 179B was
incubated with Paju-WT and Paju–ICAM-5 cells. Cells were observed un-
der phase-contrast microscope (Olympus Provis 70) at 400
 
3
 
. The length
of the neurites was measured as the distance between the soma and the tip
of the neurite counted in three random fields.
Hippocampus and cerebellum were dissected from 19-d-old rat em-
bryos and treated with 0.5 mg/ml papain for 10 min (Worthington Bio-
chemical Corp.) in HBSS (GIBCO BRL). After washing in HBSS,
neurons suspended in Neurobasal medium (GIBCO BRL), 2% B27 sup-
plement (GIBCO BRL), 25 
 
m
 
M 
 
L
 
-glutamic acid (Sigma-Aldrich), and 1%
 
L
 
-glutamine (GIBCO BRL) were seeded at 10
 
4
 
/well density in 8-chamber
slides (Nunc) coated with laminin (50 
 
m
 
g/ml; Sigma-Aldrich), HB-GAM
(Rauvala and Peng, 1997; 50 
 
m
 
g/ml), poly-
 
DL
 
-ornithine (100 
 
m
 
g/ml; Sigma-
Aldrich), or ICAM-5 recombinant proteins (100 
 
m
 
g/ml). For inhibition as-
say, 100 
 
m
 
g/ml of each antibody or recombinant protein was added to the
culture medium. Neurons were cultured for 48 or 72 h, and were then
fixed with 4% paraformaldehyde for 25 min. After permeabilization with
0.2% Triton X-100 for 10 min, the neurons were visualized with the den-
dritic marker, antimicrotubule associated protein-2 (anti–MAP-2) mAb
(Boehringer), the axonal marker antitau mAb (Boehringer), or rabbit an-
ticytoplasmic mouse ICAM-5 antiserum for 1 h at room temperature
(Benson et al., 1998), followed by incubation with TRITC-conjugated goat
anti–rabbit and FITC-conjugated goat anti–mouse antibodies (Jackson
ImmunoResearch Laboratories, Inc.). The proportion of neurite-bearing
cells (processes longer than 1 diam of the cell body) was counted in four
random fields using a fluorescence microscope (Olympus Provis 70) at
400
 
3
 
.
 
Statistical Analysis 
 
For all the quantitations, statistical analysis of variance (ANOVA) was
used to compare the different groups in each experiment. 
 
Results
 
Expression of ICAM-5 in Transfected Neural
Crest Cells
 
To study neuronal functions of ICAM-5, we used the
human neural crest-derived cell line, Paju (Zhang et
al., 1996). This cell line does not constitutively express
ICAM-5, and therefore we transfected it with human
ICAM-5. When we stained the Paju-ICAM-5 cells with
mAbs against ICAM-5, we observed that ICAM-5 did not
distribute evenly on the membrane. It showed a bimodal
distribution to the uropods of Paju-ICAM-5 cells and to 
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cell–cell contact sites (Fig. 1, a and b). When Paju-WT
cells were cocultivated with Paju-ICAM-5 cells, localiza-
tion of ICAM-5 to cell–cell contact sites was no longer ob-
served, although the uropodal expression remained (Fig.
1, c and d; Table I). When Paju-ICAM-5 cells were cul-
tured in the presence of anti–ICAM-5 mAbs, we found
that mAbs that do not inhibit leukocyte integrin-ICAM-5
adhesion, like TL-1 (Fig. 1, g and h) and 179K, did not in-
fluence ICAM-5 colocalization much, whereas antileuko-
cyte-adhesive mAbs, like TL-3 (Fig. 1, i and j) and 179B,
blocked the colocalization at cell–cell contact sites. With
control antibody, ICAM-5 remained at sites of cell contact
(Fig. 1 e and f; Table I).
 
Homophilic Binding of Recombinant
ICAM-5 Fragments
 
Since these findings suggested that ICAM-5 can bind in a
homophilic manner, we studied this possibility in more
detail by constructing a series of extracellular domain de-
Figure 1. Colocalization of
ICAM-5 at cell–cell contact
sites in Paju neuronal cells.
Human ICAM-5 transfected
into Paju cells was expressed
at cell–cell contact sites and
the uropods of Paju-ICAM-5
cells (a and b), but not in
Paju-WT/Paju-ICAM-5 con-
tact regions (c and d). When
Paju-ICAM-5 cells were cul-
tured in the presence of the
antiadhesive-ICAM-5 mAbs,
like TL-3 (i and j), the local-
ization of ICAM-5 at contact
sites was diminished as com-
pared with treatment with
control mAb (antiglyco-
phorin A; e and f) or the
mAb TL-1 treatment (g and
h), which does not affect ad-
hesion. a, c, e, g, and i, Phase-
contrast photographs; b, d,
f, h, and j, immunofluoro-
graphs. Bars, 20 mm.
 
Table I. ICAM-5 Localization at Cell–Cell Contact Sites in the 
Paju Neuronal Crest Cell Line
 
mAb treatment Paju-WT/Paju-ICAM-5 Paju-ICAM-5/Paju-ICAM-5
 
%  (n) %  (n)
 
None 5.7 (35) 91.2 (35)
TL-1 (not antiadhesive) 88.2 (34)
TL-3 (antiadhesive) 14.3 (35)
179B (antiadhesive) 8.6 (35)
179K (not antiadhesive) 90.9 (33)
 
Data are presented as the percentage of cell–cell contact sites with ICAM-5 localized
at the sites. The concentration of each mAb was 100 
 
m
 
g/ml.
Figure 2. ICAM-5 recombinant molecules. a, A schematic repre-
sentation of the ICAM-5 constructs used. The domains are num-
bered from the NH2-terminal. Fc, Immunoglobulin Fc domain. b,
Western blot of purified ICAM-5 proteins. The positions of the
molecular weight markers are shown to the left. The left-hand gel
was made using 8% acrylamide and the right-hand gel was made
using 10% acrylamide. 
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letion constructs of ICAM-5 (Fig. 2). These truncated
ICAM-5 proteins were linked at their COOH terminals to
the Fc portion of human IgG
 
1
 
. The purity of the recombi-
nant proteins was at least 90% (Fig. 2 b). After isolation,
these constructs were incubated with Paju-WT and Paju-
ICAM-5 cells, and the binding was analyzed by flow
cytometry. Whereas recombinant proteins containing do-
mains 1–9, 1–5, 5–9, 6–9, 7–9, 6, and 7–8 ICAM-5-Fc pro-
teins, as well as ICAM-1-Fc and NCAM-Fc proteins
showed little binding to Paju-ICAM-5, truncated proteins
containing domains 1–4, 1–3, 1–2, 1, 2–5, 3–5, 4–5, 4, and 5
showed significant binding, especially the domains 1–2 and
4–5 constructs (Fig. 3). The results indicated that the ho-
mophilic interactions mainly involve the first five domains
of ICAM-5, and the reason for the low binding of domains
1–9-Fc and domains 1–5-Fc proteins might be that these
proteins were inhibited by intramolecular association.
Further support for homophilic interaction was obtained
when we coated truncated, isolated ICAM-5-Fc proteins
on plastic, and detected that biotinylated D1–2-Fc bound
especially well to various constructs containing domains
4–5 (Fig. 4 a). We further studied the effects of anti–
ICAM-5 mAbs on the interaction of D1–2 with immo-
bilized D1–9 (without Fc), and observed that mAbs
TL-3,  179B, and 179I (recognizing D1) almost completely
blocked the binding, whereas mAbs 179K, 179D, and 246E
(recognizing D2) were inactive or even increased binding
(Fig. 4 b). These data indicate that the homophilic interac-
tion takes place mainly through the binding of the NH
 
2
 
-
terminal domain 1 to domains 4–5. The homophilic binding
of ICAM-5 was Ca
 
2
 
1
 
-independent, and EDTA treatment
had no effect (not shown).
 
High Molecular Weight Form of ICAM-5
 
Earlier studies have failed to detect any aggregation of
ICAM-5–transfected mouse fibroblasts (Yoshihara et al.,
1994). This is now understandable in light of our findings
that the complete external part of ICAM-5 does not bind
to transfected cells. The rabbit ICAM-5 molecule has been
proposed to exist as a tetramer (Oka et al., 1990), and
therefore we thought that it would be important to study
ICAM-5 during development. Fig. 5 a shows that during
the first postnatal week of development of the central ner-
vous system in the rat, the molecule existed as a monomer
(Fig. 5 a) and at the tenth day of postnatal development a
high molecular weight form corresponding in molecular
weight to a tetramer began to appear (Fig. 5 a). In the
brain of adult rats, almost all ICAM-5 molecules migrated
as the high molecular weight form (Fig. 5 a). Also, in
transfected Paju-ICAM-5 cells, ICAM-5 mainly existed as
nonmonomers (Fig. 5 b). Disruption of the actin cytoskel-
eton in Paju-ICAM-5 cells by cytochalasin D (Fig. 5 b)
Figure 3. ICAM-5 binds in a homophilic manner. Paju-WT and
Paju-ICAM-5 cells were stained with truncated ICAM-5-Fc pro-
teins and analyzed by flow cytometry. The values obtained with
Paju-WT were subtracted from the Paju-ICAM-5 values. Note
that D1–2-Fc and D4–5-Fc of ICAM-5 gave especially strong
binding to Paju-ICAM-5 cells, as compared with the other pro-
teins.
Figure 4. Homophilic binding of ICAM-5 D1–2-Fc to different
ICAM-5-Fc constructs. When the binding of biotinylated D1–
2-Fc of ICAM-5 to immobilized truncated ICAM-5-Fc proteins
was studied, direct binding was observed between D1–2 and
D4–5 containing proteins (a). The ICAM-5 mAbs 179B, 179I,
and TL-3 (all recognizing domain 1) blocked the binding of D1–
2-Fc to immobilized D1–9 of ICAM-5 (b). The Ig-domains of
ICAM-5, which are recognized by the respective antibodies are
shown in parentheses. Co, Control mouse IgG. SDs are shown. 
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brought most of ICAM-5 into the monomer form. Incuba-
tion of Paju-ICAM-5 cells with the ICAM-5 D1–2-Fc pro-
tein (Fig. 5 b) also resulted in monomers.
 
ICAM-5 Homophilic Interaction Promotes Neurite 
Outgrowth from Paju Cells and Is Involved in 
Dendritogenesis and Arborization of Rat
Hippocampal Neurons
 
When we coated ICAM-5 D1–9-Fc on plastic, and then
seeded Paju-WT or Paju-ICAM-5 cells, we observed neu-
rites extending from Paju-ICAM-5 cells (Fig. 6 b), but not
from Paju-WT cells (Fig. 6 a). When coated on ICAM-5
D1–2, the effect was more pronounced (Fig. 6 d). In the
presence of mAb 179B, the neurite extension from Paju-
ICAM-5 cells was inhibited (Fig. 6 f). We found signifi-
cantly less neurites from either type of cells on ICAM-1-Fc
coated surfaces (Fig. 6, g and h; Table II).
We then tested if ICAM-5 is involved in the dendritic
outgrowth using ICAM-5–expressing rat hippocampal neu-
rons and rat cerebellar neurons, which do not express
ICAM-5. By staining the neurons with the dendritic
marker, MAP-2, and the axonal marker, tau (Fig. 7), we
found that rat hippocampal neurons were induced for
dendritic outgrowth on surfaces coated with ICAM-5 D1–
9-Fc, D1–2-Fc, laminin, heparin-binding growth-associ-
ated molecule (HB-GAM), or poly-
 
DL
 
-ornithine (Fig. 7 a),
but not on ICAM-1-Fc. Interestingly, the morphology of
dendrites induced by the different molecules was different
from one another; the most dramatic difference was seen
on ICAM-5 coated surfaces (Fig. 7, a and b), which in-
duced a network of dendritic arbors. When we calculated
the number of major dendritic branches extending from
the cell soma, there was no significant difference in neurite
induction by these molecules (with exception of ICAM-1;
 
P
 
 . 
 
0.01). Fig. 7 b, left, shows double staining of MAP-2
(green) and ICAM-5 (red). Coexpression of MAP-2 and
ICAM-5 was seen (yellow), indicating that ICAM-5 is
largely dendrite-associated. Fig. 7 b, right, shows that
ICAM-5 (red) is strongly stained on neurons grown on
ICAM-5 and little tau staining (green) was seen. In con-
trast, when cells were coated on laminin, tau staining was
evident. Furthermore, the axonal arbors were more com-
plex on laminin than on ICAM-5 (Fig. 7 b, right), while the
dendritic arbors were more extensive on ICAM-5 than on
laminin (Fig. 7 b, left). In comparison to hippocampal neu-
Figure 5. Membrane-bound ICAM-5 undergoes monomer/non-
monomer transition in rat brain (a) and Paju-ICAM-5 cells (b).
Brain homogenates or Paju-ICAM-5 cell lysates with or without
indicated pretreatments were run on PhastGel 4-15 under native
conditions, and were then blotted with a polyclonal antibody
against the cytoplasmic part of ICAM-5. In rat brain, ICAM-5
was not expressed at E19, but present after birth. At postnatal 1
(P1), 4 (P4), and 7 (P7) days, ICAM-5 mainly existed as mono-
mers of 140 kD, while it partially changed to nonmonomers
(which could be tetramers) of 550 kD at P10. Brains from adult
rats contained only nonmonomers. In Paju-ICAM-5 cells (b),
ICAM-5 existed mainly as nonmonomers, with a minor monomer
component. If the cells were pretreated with 5 mM cytochalasin
D or 0.5 mg/ml ICAM-5 D1–2-Fc protein, most of membrane-
bound ICAM-5 was brought into monomers.
Figure 6. Paju-ICAM-5 cells induced for neurite outgrowth by
ICAM-5. When Paju-WT and Paju-ICAM-5 cells were seeded on
immobilized ICAM-5 D1–9-Fc or D1–2-Fc proteins, neurite out-
growth was clearly seen with Paju-ICAM-5 cells, but not with
Paju-WT cells. mAb 179B inhibited neurite outgrowth of Paju-
ICAM-5 cells, but had no effect on Paju-WT cells. Neither Paju-
ICAM-5 nor Paju-WT cells developed neurites on ICAM-1-Fc
protein. Bars, 20 mm.
 
Table II. Neurite Outgrowth of Paju Cells
 
Length of neurites
Substrate Paju-WT Paju-ICAM-5
 
m
 
m (n)
 
m
 
m (n)
 
ICAM-1-Fc 4 
 
6
 
 2 (70) 3 
 
6
 
 2 (68)
ICAM-5 D1–2-Fc 4 
 
6
 
 1 (75) 43 
 
6
 
 10 (72)
ICAM-5 D1–2-Fc 
 
1
 
 mAb 179B 6 
 
6
 
 3 (66) 12 
 
6
 
 3 (65)
 
Each substrate was coated at a concentration of 10 
 
m
 
g/ml. mAb 179B was used at 50
 
m
 
g/ml. Length of neurites is shown in micrometers, mean 
 
6
 
 SD. 
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rons, the cerebellar neurons, which do not express ICAM-5,
showed significantly less capability of dendritic outgrowth
on ICAM-5 coated surfaces than on the surfaces coated
with the other molecules (Fig. 7 c). Table III shows a quan-
titation of the ICAM-5–induced dendrite outgrowth.
To block the function of endogenous ICAM-5 expressed
on hippocampal neurons, we coated them with ICAM-5
D1–2-Fc and then incubated the hippocampal neurons
with antibodies and ICAMs in the medium. We found that
an antiserum against rat ICAM-5 (pAb 1000J) signifi-
cantly inhibited dendritic outgrowth, as compared with a
control serum (Fig. 8 a). Soluble ICAM-5 D1–2-Fc, but
not ICAM-1-Fc, also showed a significant blocking effect.
The effect of these proteins was quantitated and shown in
Fig. 8 b.
 
Discussion
 
Neurons are known for their elaborate subcellular struc-
tures that enable the transmission of signals from one cell
to another. To be meaningful, they must make precise
connections with their respective target cells (Goodman
and Shatz, 1993). This developmental process includes ax-
onal and dendritic elongation, axonal guidance, and adhe-
sive interactions between axonal growth cones and soma-
dendritic membranes of target neurons that give rise to the
formation of synaptic connections. Although much is
known about axonal elongation and guidance (Tessier-
Lavigne and Goodman, 1996; Cook et al., 1998), little is
known about dendritic development and how dendrites
participate in synaptic interaction.
A number of factors are known to be involved in axonal
guidance, including diffusible or surface-bound growth-
promoting molecules and various adhesion molecules
(Jessell, 1988), such as cadherins (Takeichi, 1991; Tamura
et al., 1998), integrins (Hynes, 1992), and immunoglobulin
superfamily molecules (Sonderegger and Rathjen, 1992;
Goodman and Shatz, 1993). In contrast, only ICAM-5 has
been shown to have a restricted expression to soma-den-
dritic membranes of telencephalic neurons (Yoshihara et
al., 1994; Benson et al., 1998). The immunofluorescence
studies show that ICAM-5 had a similar distribution as the
dendritic marker MAP-2. MAP-2 evidently also stained
some axons (Fig. 7 b), probably due to the fact that the
neurons at this stage are not absolutely polarized. In con-
trast, axon staining with antitau showed a different dis-
tribution and little overlap was seen in cells grown on
Figure 7 (continues on facing page).
 
Table III. Quantitation of Rat Hippocampal Neurons 
Expressing Axons or Dendrites
 
Percentage of neurons with 
Coated protein Axons Dendrites
 
%%
 
Laminin 72 
 
6
 
 8.0 20 
 
6
 
 9.2
ICAM-5 D1–2 7.5 
 
6
 
 2.5 63 
 
6
 
 6.5
ICAM-5 D1–9 6.5 
 
6
 
 3.8 52 
 
6
 
 8.2
 
80 neurons were studied for each protein. 50 
 
m
 
g/ml of laminin and 100 
 
m
 
g/ml of
ICAM-5 was used for coating. The cells were grown for 72 h. Axons were identified
by antitau staining and dendrites were identified by double-staining with anti–ICAM-5
and MAP-2. 
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Figure 7. ICAM-5 promotes den-
dritic outgrowth from rat hippo-
campal neurons. Rat E19 hippo-
campal or cerebellar neurons were
cultured on different substrate
coated surfaces for 48 (a) and 72 h
(b), and were then visualized by
staining with the dendritic marker,
MAP-2 (a and b), and axonal
marker, tau (b) together with anti–
ICAM-5 polyclonal antibody. The
proportion of neurons with neu-
rites was quantitated (c). All photo-
graphs were taken at 4003. Bars, 20
mm. In a, neurites from hippocam-
pal neurons were induced on
ICAM-5 D1–9, ICAM-5 D1–2,
laminin, HB-GAM, or poly-DL-orni-
thine coated surfaces, but not on
ICAM-1 coated plates. Note the
more elaborate network of neurites
induced by ICAM-5 than on lami-
nin, HB-GAM, or poly-DL-orni-
thine. b, Shows double-staining of
the dendritic marker MAP-2 with
FITC-labeled antibody (green, left)
and ICAM-5 with TRITC-labeled
antibody (red). On the right, the ex-
pression of the axonal marker tau
has been studied using FITC-
labeled antibody and ICAM-5 has
been stained with TRITC. The yel-
low staining in the left shows that
MAP-2 and ICAM-5 are largely co-
expressed, whereas it is evident
from the right that ICAM-5 and ax-
ons have a different distribution.
The results show that laminin pro-
moted the development of an ax-
onal network much better than
ICAM-5, whereas ICAM-5 pro-
moted dendritic outgrowth. c,
Shows that ICAM-5 D1–2 and
D1–9 induced similar amounts
of neurite-containing hippocampal
neurons (black bars) as the other
substrates, except for ICAM-1,
which had almost no neurite-pro-
moting effect. Cerebellar neurons
(white bars) showed less neurite
outgrowth than hippocampal neu-
rons, especially on ICAM-5 coated
surfaces. In all cases, 100 neurons
were examined. SDs are shown. 
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ICAM-5. When coated on laminin, a number of tau
 
1
 
 neu-
rites were seen. The stainings indicate that ICAM-5 pro-
motes the expression of dendritic proteins, such as MAP-2,
much better than laminin, whereas laminin promotes the
expression of axonal proteins such as tau.
Although the function of ICAM-5 as a brain-specific
leukocyte-binding protein is well established (Mizuno et
al., 1997; Tian et al., 1997), its strong and specific expres-
sion in the telencephalon, especially in the cerebrum and
hippocampus, indicated that it may possess other func-
tions. Here, we describe that ICAM-5 induces dendritic
extension and branching through homophilic adhesion,
the effect of which is dramatically different from that of
laminin (Höpker et al., 1999) or HG-GAM (Rauvala and
Figure 8. Inhibition of den-
dritic outgrowth from hip-
pocampal neurons by anti–
ICAM-5 antiserum or soluble
ICAM-5 D1–2 or ICAM-1. a,
Rat E19 hippocampal neu-
rons were cultured on
ICAM-5 D1–2 coated sur-
faces for 48 h. The neurons
were stained by anti–MAP-2
(red) and anti–ICAM-5
(green). The polyclonal anti-
body against rat ICAM-5,
1000J (100 mg/ml), signifi-
cantly inhibited dendrite out-
growth, compared with the
control polyclonal serum (ctrl
pAb). A similar inhibitory ef-
fect was seen with soluble
ICAM-5 D1–2 (100 mg/ml),
but not with ICAM-1. Ar-
rows indicate neurites that
may be axons stained by
anti–MAP-2, but not by anti–
ICAM-5. Bars, 20 mm. In b,
the number of dendrite-bear-
ing hippocampal neurons
subjected to different treat-
ments was counted. 100 neu-
rons in each case were exam-
ined.  
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Peng, 1997), which are known to mainly promote axonal
outgrowth, and that this activity can be blocked by mAbs
against ICAM-5.
The first indication of homophilic binding was obtained
when we observed that ICAM-5 transfected in Paju cells
was enriched at the cell–cell contact sites. However, when
we made the entire external part of ICAM-5 by recombi-
nant methods, it did not show homophilic binding. This is-
sue was then studied by making truncated shorter con-
structs of the molecule. We then found that the binding
activity was mediated by homophilic binding of the NH
 
2
 
-
terminal domain 1 to domains 4–5. Constructs containing
domains 1–2 were more efficient in binding than the single
first domain. The finding that mAbs reacting with domain
2 did not inhibit binding further indicates that domain 2 is
not directly involved in binding. In fact, some antibodies
to D2 enhanced binding, which could be due to conforma-
tional changes in D1. The reason for the inability of the
isolated D1–9 construct to mediate binding could be its
strong tendency to form higher aggregates, possibly tet-
ramers in vitro.
When we performed an analysis of the calculated pI val-
ues of the ICAM-5 extracellular domains, we found that in
all species of cloned ICAM-5, the pI values of domains 1–2
were 
 
z
 
11.3, whereas those of domains 4–5 were 
 
z
 
4.3, sug-
gesting that the homophilic interaction of D1 with D4–5
could be at least partially mediated by electrostatic inter-
actions between the respective domains. This characteris-
tic of highly oppositely charged domains in ICAM-5 is
unique among the ICAMs. This may be the reason that
ICAM-1 did not show any homophilic binding. Nor did
ICAM-1 bind ICAM-5, which shows that the binding is
highly specific.
Earlier studies on neural adhesion molecules have
shown that the homophilic binding of the neuronal cell ad-
hesion molecule (NCAM) involves all of the five Ig do-
mains (Ranheim et al., 1996), whereas in the case of L1
and cadherin, only Ig domain 2 in L1 (Zhao and Siu, 1995)
and domain 1 in cadherin (Tamura et al., 1998) are in-
volved. The complex phenomena of homophilic binding of
different cell adhesion molecules must underlie their dif-
ferent functions, not only in adhesion, but also in possible
signaling events (Brümmendorf and Rathjen, 1996).
Multimerization of cell surface molecules is commonly
believed to enhance the binding to their ligands/receptors
through an increase in avidity. Such examples are the ho-
modimerization of cadherin (Tamura et al., 1998) and
ICAM-1 (Miller et al., 1998), and the heterodimerization
of NgCAM and axonin-1 (Kunz et al., 1998). The behavior
of ICAM-5 is different from that of the other studied Ig
domain-containing adhesion proteins.
We think that the inability of the ICAM-5 high molecu-
lar weight form to adhere is due to the fact that the ho-
mophilic binding of ICAM-5 requires a deeper accessibil-
ity of two opposite polypeptides. Furthermore, the studies
with the truncated ICAM-5 molecules show that intramo-
lecular associations may exist. The short constructs, like
D1–2, can bind because they have their binding domains
accessible, whereas longer constructs, like D1–5, are inac-
tive because of interpolypeptide association between D1
and D4–5.
High local concentrations of ICAM-5 may promote high
molecular weight complex formation as seen in Paju cells
where the uropods are especially rich in the protein. The
nonmonomer state must not, however, be permanent in
vivo because when Paju-ICAM-5 cells were incubated
with truncated ICAM-5 fusion proteins containing the two
NH
 
2
 
-terminal domains, the ICAM-5 molecules cells were
brought into monomers. How this phenomenon is regu-
lated in vivo remains unknown. When Paju-ICAM-5 cells
were treated with cytochalasin D, ICAM-5 completely
switched into monomers. These facts indicate a linkage of
ICAM-5 with cytoskeletal proteins, as with other ICAM
molecules (Carpén et al., 1992; Heiska et al., 1996).
ICAM-5 was previously observed to concentrate in den-
dritic growth cones and filopodia in hippocampal neurons
(Benson et al., 1998). Experiments with cytochalasins to
disrupt actin filaments within axonal growth cones have
shown that the actin cytoskeleton is necessary for correct
pathfinding in vivo (Forscher and Smith, 1988; Sheetz et
al., 1992; Chien et al., 1993), and for directed neurite out-
growth in vitro (Smith, 1988; Sheetz et al., 1992). The
binding of adhesion molecules on the surface of cells may
mediate changes in the cytoskeletal scaffold, thereby re-
sulting in stabilized adhesion or forward growth (Lin et
al., 1994). The dynamic change of adhesiveness between
monomers and nonmonomers of ICAM-5, which may be
regulated by the cytoskeleton, offers an interesting possi-
bility of regulation of dendritic outgrowth.
Regulation of ICAM-5 binding by nonmonomer/mono-
mer transition could also be a means of influencing leuko-
cyte integrin–ICAM-5 interaction. We have found that
CD11a/CD18 binds to the first Ig domain of ICAM-5
(Tian et al., 2000), and some mAbs that blocked the
ICAM-5-integrin interaction also blocked the ICAM-5 ho-
mophilic binding, so the binding sites for these two activi-
ties are partially overlapping.
It has been known that dendritogenesis and synaptogen-
esis take place during the early postnatal period (Good-
man and Shatz, 1993; Craig and Banker, 1994). Therefore,
we studied ICAM-5 during this time in rats where brain
development has been extensively studied (Craig and
Banker, 1994). Interestingly, during the first postnatal
week, ICAM-5 mainly existed as monomers, whereas at
postnatal days 7–10, it gradually changed into nonmono-
mers. Whether the nonmonomer form is a tetramer or a
complex of ICAM-5 with other proteins is not known. This
transition coincides with dendritogenesis in the early post-
natal period of the rodent central nervous system. Obvi-
ously, it is important that when neurons extend branches
of dendrites they also need signals for distinguishing ax-
onal growth cones from dendritic ones so that the correct
synapses are formed. At an early stage of dendritogenesis,
ICAM-5 monomers could promote dendritic elongation
and arborization through homophilic interaction. When
neurons become developmentally more mature, ICAM-5
mainly exists as nonmonomers, whereby it does not pro-
mote dendrite–dendrite/soma interactions. It is possible
that promotion of dendrite–dendrite adhesion by mono-
meric ICAM-5 does not promote branching, and con-
versely, that the nonmonomeric form could induce more
branching.
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